Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 520

1.

TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.

Yen ML, Tsai HF, Wu YY, Hwa HL, Lee BH, Hsu PN.

Mol Immunol. 2008 Apr;45(8):2205-13. doi: 10.1016/j.molimm.2007.12.003.

PMID:
18206242
2.

TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.

Zauli G, Rimondi E, Nicolin V, Melloni E, Celeghini C, Secchiero P.

Blood. 2004 Oct 1;104(7):2044-50.

3.

TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation.

Yen ML, Hsu PN, Liao HJ, Lee BH, Tsai HF.

PLoS One. 2012;7(6):e38048. doi: 10.1371/journal.pone.0038048.

4.

Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.

Kim MH, Ryu SY, Bae MA, Choi JS, Min YK, Kim SH.

Food Chem Toxicol. 2008 Nov;46(11):3375-82. doi: 10.1016/j.fct.2008.08.016.

PMID:
18786594
5.

Ribosome inactivating protein B-chain induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.

Wang YM, Lu TL, Hsu PN, Tang CH, Chen JH, Liu KC, Kao JT, Tzen JT, Wu YY.

Bone. 2011 Jun 1;48(6):1336-45. doi: 10.1016/j.bone.2011.02.018.

PMID:
21356340
6.
7.

Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.

Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, Lou H, Delaissé JM, Foged NT.

J Biol Chem. 2003 Nov 7;278(45):44975-87.

8.

Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways.

Berg D, Stühmer T, Siegmund D, Müller N, Giner T, Dittrich-Breiholz O, Kracht M, Bargou R, Wajant H.

FEBS J. 2009 Dec;276(23):6912-27. doi: 10.1111/j.1742-4658.2009.07388.x.

9.

Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.

Park H, Jung YK, Park OJ, Lee YJ, Choi JY, Choi Y.

J Immunol. 2005 Dec 1;175(11):7193-201.

10.

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.

Varfolomeev E, Maecker H, Sharp D, Lawrence D, Renz M, Vucic D, Ashkenazi A.

J Biol Chem. 2005 Dec 9;280(49):40599-608.

11.

Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway.

Chamoux E, Houde N, L'Eriger K, Roux S.

J Cell Physiol. 2008 Aug;216(2):536-42. doi: 10.1002/jcp.21430.

PMID:
18338379
12.

Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation.

Park EK, Kim MS, Lee SH, Kim KH, Park JY, Kim TH, Lee IS, Woo JT, Jung JC, Shin HI, Choi JY, Kim SY.

Biochem Biophys Res Commun. 2004 Dec 24;325(4):1472-80.

PMID:
15555594
13.

Inhibition of osteoclast differentiation and bone resorption by sauchinone.

Han KY, Yang D, Chang EJ, Lee Y, Huang H, Sung SH, Lee ZH, Kim YC, Kim HH.

Biochem Pharmacol. 2007 Sep 15;74(6):911-23.

PMID:
17662251
14.

Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha.

Lee SK, Huang H, Lee SW, Kim KH, Kim KK, Kim HM, Lee ZH, Kim HH.

Exp Cell Res. 2004 Aug 15;298(2):359-68.

PMID:
15265685
15.

TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype.

Fox SW, Fuller K, Bayley KE, Lean JM, Chambers TJ.

J Immunol. 2000 Nov 1;165(9):4957-63.

16.

Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.

Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.

J Cell Physiol. 2008 Nov;217(2):409-22. doi: 10.1002/jcp.21511.

PMID:
18543257
17.

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts.

Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A.

J Biol Chem. 2000 Feb 18;275(7):4858-64.

18.

Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway.

Secchiero P, Gonelli A, Mirandola P, Melloni E, Zamai L, Celeghini C, Milani D, Zauli G.

Blood. 2002 Oct 1;100(7):2421-9.

19.

Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-kappa B ligand.

Mochizuki A, Takami M, Kawawa T, Suzumoto R, Sasaki T, Shiba A, Tsukasaki H, Zhao B, Yasuhara R, Suzawa T, Miyamoto Y, Choi Y, Kamijo R.

J Immunol. 2006 Oct 1;177(7):4360-8.

20.

An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.

Heath DJ, Vanderkerken K, Cheng X, Gallagher O, Prideaux M, Murali R, Croucher PI.

Cancer Res. 2007 Jan 1;67(1):202-8.

Supplemental Content

Support Center